Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: Evidence for an increased sensitivity to Fas-mediated apoptosis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 13, Issue 1, 2003, Pages 39-44

  Neale, D ^a   Demasio, K ^a   Illuzi, J ^a   Chaiworapongsa, T ^b   Romero, R ^b   Mor, G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Apoptosis; Cytokines; Fas fasL; Pre eclampsia; Trophoblast

Indexed keywords

FAS ANTIBODY; FAS LIGAND;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL CULTURE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; MATERNAL SERUM; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; TROPHOBLAST;

EID: 0037275036     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.13.1.39.44     Document Type: Article

References (66)

1. Roberts JM. Pregnancy related hypertension. In Creasy RK, Resnik R, eds. Maternal Fetal Medicine. Philadelphia: WB Saunders, 1998:883-92
2. Elmer DB, Granai CO, Ball HG, et al. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole. Obstet Gynecol 1993;81:888-90
3. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. J Am Med Assoc 2002;287:3183-6
4. Romero R, Lockwood C, Oyarzun E, et al. Toxemia: new concepts in an old disease. Semin Perinatol 1988;12:302-23
5. Gyongyossy A, Kelentey B. An experimental study of the effect of ischaemia of the pregnant uterus on the blood pressure. J Obstet Gynaecol Br Commonw 1958;65:624
6. Hadori AA. Chronic uterine ischemia and reversible experimental 'toxemia of pregnancy'. Am J Obstet Gynecol 1967;97:597-607
7. Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1938;37:291-3
8. Page EW. The physiology of hypertension in eclampsia. Am J Obstet Gynecol 1939;38:230-9
9. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5-15
10. Chua S, Wilkins T, Sargent I, et al. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991;98:973-9
11. Johansen M, Redman CW, Wilkins T, et al. Trophoblast deportation in human pregnancy - its relevance for pre-eclampsia. Placenta 1999;20:531-9
12. Knight M, Redman CW, Linton EA, et al. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998;105:632-40
13. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999;20:114-18
14. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506
15. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta 2000;21:597-602
16. Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001;185:792-7
17. Redman CW, Sargent IL. The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 2001;29:518-22
18. von Dadelszen P, Hurst G, Redman CW. Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum Reprod 1999;14:919-24
19. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8
20. Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol 1994;57:129-44
21. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65
22. Israels LG, Israels ED. Apoptosis. Stem Cells 1999;17:306-13
23. Buemi M, Allegra A, D'Anna R, et al. Is apoptosis cause of pre-eclampsia? Eur Rev Med Pharmacol Sci 1998;2:185-8
24. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Gorzelak B, et al. Fas antigen expression on the decidual lymphocytes of pre-eclamptic patients. Am J Reprod Immunol 2000;43:197-201
25. Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, et al. The expression and concentrations of Fas/APO-1 (CD95) antigen in patients with severe pre-eclampsia. J Reprod Immunol 2001;49:153-64
26. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999;155:293-301
27. Genbacev O, DiFederico E, McMaster M, et al. Invasive cytotrophoblast apoptosis in pre-eclampsia. Hum Reprod 1999;14 (Suppl 2):59-66
28. Ishihara N, Matsuo H, Murakoshi H, et al. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158-66
29. Leung DN, Smith SC, To KF, et al. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001;184:1249-50
30. von Dadelszen P, Watson RW, Noorwali F, et al. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999;181:408-14
31. Jerzak M, Bischof P. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling. Eur J Obstet Gynecol Reprod Biol 2002;100:138-42
32. Mundle SD, Raza A. Defining the dynamics of self-assembled Fas-receptor activation. Trends Immunol 2002;23:187-94
33. Selam B, Kayisli UA, Garcia-Velasco JA, et al. Regulation of fas ligand expression by IL-8 in human endometrium. J Clin Endocrinol Metab 2002;87:3921-7
34. Song J, Sapi E, Brown W, et al. Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest 2000;106:1209-20
35. Song J, Rutherford T, Naftolin F, et al. Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells. Mol Hum Reprod 2002;8:447-55
36. Redman CW. Platelets and the beginnings of preeclampsia. N Engl J Med 1990;323:478-80
37. Lubega J. Thrombin receptor on the placental syncytiotrophoblastic plasma membrane. Ric Clin Lab 1990;20:203-8
38. Reverdiau P, Jarousseau AC, Thibault G, et al. Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture. Thromb Haemost 1995;73:49-54
39. Levine RJ, Esterlitz JR, Raymond EG, et al. Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods. Control Clin Trials 1996;17:442-69
40. Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993;303:474-82
41. Williams J. Premature seperation of the normally implanted placenta. Surg Gynecol Obstet 1915;21:541-54
42. Chesley LC, McFaul IE. Studies on surviving human placental tissue. I. A search for pressor and antidiuretic factor. Am J Obstet Gynecol 1949;58:159
43. Hunter CA Jr, Howard WF. A pressor substance (hysterotonin) occuring in toxemia. Am J Obstet Gynecol 1960;79:838
44. Page EW, Cox AJ. Renal changes following toxaemias of late pregnancy. West J Surg 1983;46:463
45. Tatum HJ, Mule JG. The hypertensive action of blood from preeclampsia. Am J Obstet Gynecol 1962;83:1028-34
46. Pirani BB, MacGillivray I. The effect of plasma retransfusion on the blood pressure in the puerperium. Am J Obstet Gynecol 1975;121:221-6
47. Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-9
48. Gant NF, Chand S, Whalley PJ, et al. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974;43:854
49. Li C, Ansari R, Yu Z, et al. Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension 2000;36:159-64
50. Shah DM. Perinatal implications of maternal hypertension. Semin Pediatr Neurol 2001;8:108-19
51. Talledo DE, Chesley LC, Zuspan FP. Renin-angiotensin system in normal and toxemic pregnancies. III. Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. Am J Obstet Gynecol 1968;100:218-21
52. Zuspan FP. Catecholamines. Their role in pregnancy and the development of pregnancy-induced hypertension. J Reprod Med 1979;23:143-50
53. Krege JH, Katz VL. A proposed relationship between vasopressinase altered vasopressin and preeclampsia. Med Hypotheses 1990;31:283-7
54. McKinney ET, Shouri R, Hunt RS, et al. Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. Am J Obstet Gynecol 2000;183:874-7
55. Clark BA, Halvorson L, Sachs B, et al. Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 1992;166:962-8
56. Pedersen EB, Aalkjaer C, Christensen NJ, et al. Renin, angiotensin II, aldosterone, catecholamines, prostaglandins and vasopressin. The importance of pressor and depressor factors for hypertension in pregnancy. Scand J Clin Lab Invest Suppl 1984;169:48-56
57. Huppertz B, Frank HG, Kingdom JC, et al. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998;110:495-508
58. Huppertz B, Frank HG, Kaufmann P. The apoptosis cascade - morphological and immunohistochemical methods for its visualization. Anat Embryol (Berl) 1999;200:1-18
59. Huppertz B, Frank HG, Reister F, et al. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest 1999;79:1687-702
60. Reister F, Frank HG, Kingdom JC, et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001;81:1143-52
61. Lea RG, Riley SC, Antipatis C, et al. Cytokines and the regulation of apoptosis in reproductive tissues: a review. Am J Reprod Immunol 1999;42:100-9
62. Greer IA, Lyall F, Perera T, et al. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994;84:937-40
63. Teran E, Escudero C, Moya W, et al. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet 2001;75:243-9
64. Visser W, Beckmann I, Knook MA, et al. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in pre-eclampsia. Acta Obstet Gynecol Scand 2002;81:713-19
65. Aschkenazi S, Straszewski S, Verwer KM, et al. Differential regulation and function of the fas/fas ligand system in human trophoblast cells. Biol Reprod 2002;66:1853-61
66. Mor G, Gutierrez LS, Eliza M, et al. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol 1998;40:89-94